SomaLogic Operating Co. Inc.

Breadcrumb

SomaLogic Operating Co. Inc.

SomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility.听

The CU Boulder Connection

Professor Larry Gold (MCDB) founded SomaLogic, which pioneered the development of proteomics diagnostics and assays based on Gold鈥檚 SELEX technology. After going public in 2021, SomaLogic announced a merger with .

Funding Status and Investment Opportunities

Industry: Biotech鈥�, Genomics, Health and Wellness鈥�, Therapeutics, Diagnostics
Funding Stage: Exit
Contact for Investment Inquiries: Standard Bio Tools Inc. (LAB)

In the News

(2023)
Standard BioTools completes merger with SomaLogic, a CU Boulder spinout听(2023)
SomaLogic to merge with Standard BioTools in all-stock deal听(2023)
SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe听(2023)
SomaLogic acquires DNA nanotechnology leader Palamedrix听(2022)
SomaLogic to aid in cancer research听(2022)
SomaLogic predicts $110M in 2022 revenue听(2022)
SomaLogic to go public via SPAC in deal that values it as a unicorn听(2021)

More Startups News

CU Boulder Programs鈥�

Intellectual Property Management (1999)

Path to Commercialization

听听This page was last updated Nov. 13, 2023. Please contact us for corrections or updates

The Insider E-Newsletter

The Insider听is听Venture Partners at CU Boulder's monthly newsletter featuring the听latest headlines, news, events, opportunities and emerging innovations coming out of the university. We have several editions for our audiences:

Inventors and听Researchers (Monthly)
Community (Monthly)
Investors (Quarterly)

View the latest Insiders Subscribe to The Insider

Questions about investment opportunities?

Stephen S. Miller

Please contact Bryn Rees, managing director of Venture Partners at CU Boulder

Contact

Media inquiries?

Please contact Daniel Leonard,听senior marketing and communications specialist

Contact

麻豆视频

Main menu